X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/20/2901682/0/en/Allogene-Therapeutics-Initiates-Pivotal-Phase-2-Trial-Investigating-Cemacabtagene-Ansegedleucel-cema-cel-an-Allogeneic-CAR-T-Product-as-Part-of-First-Line-Treatment-for-Patients-wi.html
https://www.globenewswire.com/news-release/2024/05/23/2887265/0/en/Allogene-Therapeutics-Announces-Participation-in-the-TD-Cowen-5th-Annual-Oncology-Innovation-Summit.html
https://ir.allogene.com/news-releases/news-release-details/allogene-therapeutics-announces-pricing-110-million-offering
https://www.globenewswire.com/news-release/2024/05/13/2880920/0/en/Allogene-Therapeutics-Announces-Pricing-of-110-million-Offering-of-Common-Stock.html
https://www.globenewswire.com/news-release/2024/05/13/2880847/0/en/Allogene-Therapeutics-Reports-First-Quarter-2024-Financial-Results-and-Business-Update.html
https://www.globenewswire.com/news-release/2024/05/06/2875836/0/en/Allogene-Therapeutics-to-Report-First-Quarter-Financial-Results-and-Provide-Business-Update.html
https://www.globenewswire.com/news-release/2024/04/26/2870462/0/en/Allogene-Therapeutics-Awarded-Grant-from-the-California-Institute-for-Regenerative-Medicine-to-Advance-Development-of-an-Allogeneic-CAR-T-in-Renal-Cell-Carcinoma.html
https://www.globenewswire.com/news-release/2024/04/09/2859999/0/en/Allogene-Therapeutics-Announces-Q2-Investor-Conference-Participation.html
https://www.globenewswire.com//news-release/2024/03/14/2846685/0/en/Allogene-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Business-Update.html
https://www.globenewswire.com//news-release/2024/03/12/2844522/0/en/Allogene-Therapeutics-and-Arbor-Biotechnologies-Announce-Global-Gene-Editing-Licensing-Agreement-to-Support-Advancement-of-Next-Generation-Allogeneic-CAR-T-Platform-in-Autoimmune-D.html
Market Place
Share 
